Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(7 sites)

China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong

The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong

Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong

The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

The First People's Hospital of Foshan, Guangzhou, Guangdong

Zhongshan People's Hospital, Zhongshan, Guangdong

The Tenth Affiliated Hospital, Sun Yat-Sen University, Nanchang, Jiangxi